Physician profile
Robert S Wark
NPI 1730181769
$3,560.71
in general payments reported to CMS, 2019-2025
11 companies · $257 in 2025
The $257 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,235 · 2020: $39.86 · 2022: $20.32 · 2023: $385 · 2024: $624 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,265.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,070.61 | 2019-2025 | Watchman Flx, Watchman Access System, Versacross Access Solution |
| Medtronic Vascular, INC. | $906.66 | 2019 | |
| Abbott Laboratories | $196.35 | 2022-2024 | Ensite Precision, Amplatzer Talisman |
| Otsuka America Pharmaceutical, INC. | $99.05 | 2019-2020 | |
| Medtronic, INC. | $82.02 | 2023-2024 | Onyx Frontier, Micra, Flexcath Advance |
| Abiomed | $79.66 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.56 | 2019 | |
| Janssen Pharmaceuticals, INC | $33.21 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.63 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.22 | 2024 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $15.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.